|
Name |
24-α-D-glucosyl-(-)-terpestacin
|
Molecular Formula | C31H48O9 | |
IUPAC Name* |
5,17-dihydroxy-4,8,12,15-tetramethyl-18-[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]bicyclo[13.3.0]octadeca-3,8,12,17-tetraen-16-one
|
|
SMILES |
CC1=CCC2(C)C(=O)C(O)=C(C(C)COC3OC(CO)C(O)C(O)C3O)C2CC=C(C)C(O)CCC(C)=CCC1
|
|
InChI |
InChI=1S/C31H48O9/c1-17-7-6-8-18(2)13-14-31(5)21(11-10-19(3)22(33)12-9-17)24(26(35)29(31)38)20(4)16-39-30-28(37)27(36)25(34)23(15-32)40-30/h7,10,13,20-23,25,27-28,30,32-37H,6,8-9,11-12,14-16H2,1-5H3/b17-7+,18-13+,19-10+/t20-,21-,22+,23-,25-,27+,28-,30+,31+/m1/s1
|
|
InChIKey |
RVSWMQVCYJCHMC-MEDLHAJDSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 564.72 | ALogp: | 3.0 |
HBD: | 6 | HBA: | 9 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 156.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 40 | QED Weighted: | 0.273 |
Caco-2 Permeability: | -5.282 | MDCK Permeability: | 0.00000913 |
Pgp-inhibitor: | 0.98 | Pgp-substrate: | 0.075 |
Human Intestinal Absorption (HIA): | 0.944 | 20% Bioavailability (F20%): | 0.297 |
30% Bioavailability (F30%): | 0.96 |
Blood-Brain-Barrier Penetration (BBB): | 0.09 | Plasma Protein Binding (PPB): | 84.74% |
Volume Distribution (VD): | 1.61 | Fu: | 8.02% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.117 |
CYP2C19-inhibitor: | 0.008 | CYP2C19-substrate: | 0.269 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.151 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.077 |
CYP3A4-inhibitor: | 0.039 | CYP3A4-substrate: | 0.222 |
Clearance (CL): | 1.386 | Half-life (T1/2): | 0.074 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.373 |
Drug-inuced Liver Injury (DILI): | 0.146 | AMES Toxicity: | 0.227 |
Rat Oral Acute Toxicity: | 0.193 | Maximum Recommended Daily Dose: | 0.702 |
Skin Sensitization: | 0.125 | Carcinogencity: | 0.596 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.435 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001882 | 0.676 | D0S0NK | 0.356 | ||||
ENC002974 | 0.676 | D06BQU | 0.283 | ||||
ENC003560 | 0.676 | D0T5BC | 0.269 | ||||
ENC003210 | 0.644 | D04RYU | 0.268 | ||||
ENC005683 | 0.602 | D0I9HF | 0.263 | ||||
ENC004376 | 0.512 | D0AR3J | 0.257 | ||||
ENC005685 | 0.488 | D0TC7C | 0.257 | ||||
ENC004109 | 0.488 | D06ALD | 0.256 | ||||
ENC005684 | 0.480 | D0H3KI | 0.241 | ||||
ENC002993 | 0.344 | D01TNW | 0.240 |